The Ambulatory Specialty Model (ASM) has the potential to reduce chronic disease costs by holding specialists accountable for ...
Follitropin delta (Rekovelle; Ferring), a recombinant follicle-stimulating hormone produced in a human cell line, achieved cumulative ongoing pregnancy rates of 64.0% in patients ...
Although zidesamtinib (Jideytro; GSK) was designed to be better tolerated than other ROS1 inhibitors, it can still cause adverse effects that require monitoring, and questions remain about how best to ...
This indicates that rusfertide works for patients broadly rather than only for a subset, he explained. For durability, ...
Michael Mina, MD, PhD, of Invivyd explains how a few amino acid changes let VYD2311 move from IV to a single IM shot that ...
Health literacy in cancer care is increasingly being treated as something health systems build rather than a ready skill ...
Medicare beneficiaries using lower-priced negotiated drugs experienced out-of-pocket savings under the Medicare Drug Price ...
Joanna Parga-Belinkie, MD, explains how framing VKDB as a stroke and documenting refusals helps her counsel parents on ...
Fathi, of Mass General Brigham Cancer Institute, says PARADIGM trial data support azacitidine-venetoclax for ...
A 2024 protocol published in BMJ Open, outlining a planned systematic review to quantify that excess burden worldwide, noted ...
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell ...
Quantitative computed tomography (CT) methods can help predict disease progression and assess the efficacy of drugs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results